20/20 Biolabs Inc Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CRESSET ASSET MANAGEMENT, LLC | 05/15/2026 | 264.37 K | $497.01 K | 100.00% | 5.44% |
| CITADEL ADVISORS LLC | 05/15/2026 | 16.23 K | $30.51 K | 100.00% | 0.33% |
| XTX TOPCO LTD | 05/15/2026 | 10.33 K | $19.42 K | 100.00% | 0.21% |
| UBS GROUP AG | 05/05/2026 | 8.31 K | $15.63 K | 100.00% | 0.17% |
| MAI CAPITAL MANAGEMENT | 05/15/2026 | 1.00 K | $1.88 K | 100.00% | 0.02% |
| TOTH FINANCIAL ADVISORY CORP | 04/16/2026 | 157 | $296 | 100.00% | 0.00% |
| ALLWORTH FINANCIAL LP | 05/15/2026 | 30 | $57 | 100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
20/20 Biolabs Inc institutional Ownership - FAQ's
During the previous two years, 7 institutional investors and hedge funds held shares of 20/20 Biolabs Inc. The most heavily invested institutionals were:
Cresset Asset Management, LLC: 264,368
CITADEL ADVISORS LLC: 16,227
XTX Topco Ltd: 10,329
UBS Group AG: 8,314
MAI Capital Management: 1,000
TOTH FINANCIAL ADVISORY CORP: 157
6.19% of 20/20 Biolabs Inc stock is owned by institutional investors.
Institutional investors have bought a total of 300.43 K shares in the last 24 months. This purchase volume represents approximately $853.21 K in transactions.